Comparative study of standard 22G needle and side-port needle used in EUS-FNAB for patients with pancreatic tumor

Comparative study of standard 22G needle and side-port needle used in EUS-FNAB for patients with pancreatic tumor - Comparative study of two type EUS-FNAB needles for pancreatic tumor

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000010421

Enrollment

138

Registered

2013-04-05

Start date

2012-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic tumor

Interventions

22G standard needle 22G side-port needle

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: pancreatic tumor's diameter >= 10mm. unresectable tumor written IC

Exclusion criteria

Exclusion criteria: pancreatic tumor's diameter < 10mm cases who will receive curative operation no written IC

Design outcomes

Primary

Measure	Time frame
over all accuracy	—

Secondary

Measure	Time frame
accuracy in each session	—

Countries

Japan

Contacts

Public ContactTESSHIN BAN

Nagoya daini red cross hospital gastroenterology

venzo@nagoya2.jrc.or.jp052-832-1121

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026